{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:44:40Z","timestamp":1789983880640,"version":"4.0.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T00:00:00Z","timestamp":1533513600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T00:00:00Z","timestamp":1533513600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["5K22CA190440"],"award-info":[{"award-number":["5K22CA190440"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["5T32GM118294"],"award-info":[{"award-number":["5T32GM118294"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000043","name":"American Association for Cancer Research","doi-asserted-by":"publisher","award":["14-20-10-LI"],"award-info":[{"award-number":["14-20-10-LI"]}],"id":[{"id":"10.13039\/100000043","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1038\/s41388-018-0425-7","type":"journal-article","created":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T10:40:42Z","timestamp":1533552042000},"page":"120-139","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Induction of store-operated calcium entry (SOCE) suppresses glioblastoma growth by inhibiting the Hippo pathway transcriptional coactivators YAP\/TAZ"],"prefix":"10.1038","volume":"38","author":[{"given":"Zhijun","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiju","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia P.","family":"Yee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuexin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Gulley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Atkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Trebak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5696-4309","authenticated-orcid":false,"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,6]]},"reference":[{"key":"425_CR1","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00401-005-0991-y","volume":"109","author":"H Ohgaki","year":"2005","unstructured":"Ohgaki H, Kleihues P. Epidemiology and etiology of gliomas. Acta Neuropathol. 2005;109:93\u2013108.","journal-title":"Acta Neuropathol"},{"key":"425_CR2","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ccr.2006.02.019","volume":"9","author":"HS Phillips","year":"2006","unstructured":"Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD, et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell. 2006;9:157\u201373.","journal-title":"Cancer Cell"},{"key":"425_CR3","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","volume":"17","author":"RG Verhaak","year":"2010","unstructured":"Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010;17:98\u2013110.","journal-title":"Cancer Cell"},{"key":"425_CR4","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1101\/gad.176800.111","volume":"25","author":"KP Bhat","year":"2011","unstructured":"Bhat KP, Salazar KL, Balasubramaniyan V, Wani K, Heathcock L, Hollingsworth F, et al. The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma. Genes Dev. 2011;25:2594\u2013609.","journal-title":"Genes Dev"},{"key":"425_CR5","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1097\/NEN.0b013e31821ff8d8","volume":"70","author":"BA Orr","year":"2011","unstructured":"Orr BA, Bai H, Odia Y, Jain D, Anders RA, Eberhart CG. Yes-associated protein 1 is widely expressed in human brain tumors and promotes glioblastoma growth. J Neuropathol Exp Neurol. 2011;70:568\u201377.","journal-title":"J Neuropathol Exp Neurol"},{"key":"425_CR6","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.cell.2015.10.044","volume":"163","author":"FX Yu","year":"2015","unstructured":"Yu FX, Zhao B, Guan KL. Hippo pathway in organ size control, tissue homeostasis, and cancer. Cell. 2015;163:811\u201328.","journal-title":"Cell"},{"key":"425_CR7","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/nrc3458","volume":"13","author":"KF Harvey","year":"2013","unstructured":"Harvey KF, Zhang X, Thomas DM. The Hippo pathway and human cancer. Nat Rev Cancer. 2013;13:246\u201357.","journal-title":"Nat Rev Cancer"},{"key":"425_CR8","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.ccell.2016.05.005","volume":"29","author":"F Zanconato","year":"2016","unstructured":"Zanconato F, Cordenonsi M, Piccolo S. YAP\/TAZ at the roots of cancer. Cancer Cell. 2016;29:783\u2013803.","journal-title":"Cancer Cell"},{"key":"425_CR9","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.bbrc.2015.05.115","volume":"463","author":"T Tian","year":"2015","unstructured":"Tian T, Li A, Lu H, Luo R, Zhang M, Li Z. TAZ promotes temozolomide resistance by upregulating MCL-1 in human glioma cells. Biochem Biophys Res Commun. 2015;463:638\u201343.","journal-title":"Biochem Biophys Res Commun"},{"key":"425_CR10","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1038\/onc.2011.379","volume":"31","author":"LA Fernandez","year":"2012","unstructured":"Fernandez LA, Squatrito M, Northcott P, Awan A, Holland EC, Taylor MD, et al. Oncogenic YAP promotes radioresistance and genomic instability in medulloblastoma through IGF2-mediated Akt activation. Oncogene. 2012;31:1923\u201337.","journal-title":"Oncogene"},{"key":"425_CR11","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.cell.2014.06.003","volume":"158","author":"A Kapoor","year":"2014","unstructured":"Kapoor A, Yao W, Ying H, Hua S, Liewen A, Wang Q, et al. Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer. Cell. 2014;158:185\u201397.","journal-title":"Cell"},{"key":"425_CR12","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.cell.2014.06.004","volume":"158","author":"DD Shao","year":"2014","unstructured":"Shao DD, Xue W, Krall EB, Bhutkar A, Piccioni F, Wang X, et al. KRAS and YAP1 converge to regulate EMT and tumor survival. Cell. 2014;158:171\u201384.","journal-title":"Cell"},{"key":"425_CR13","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/nrd4161","volume":"13","author":"R Johnson","year":"2014","unstructured":"Johnson R, Halder G. The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment. Nat Rev Drug Discov. 2014;13:63\u201379.","journal-title":"Nat Rev Drug Discov"},{"key":"425_CR14","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nrc.2017.18","volume":"17","author":"GR Monteith","year":"2017","unstructured":"Monteith GR, Prevarskaya N, Roberts-Thomson SJ. The calcium-cancer signalling nexus. Nat Rev Cancer. 2017;17:367\u201380.","journal-title":"Nat Rev Cancer"},{"key":"425_CR15","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nrc2374","volume":"8","author":"HL Roderick","year":"2008","unstructured":"Roderick HL, Cook SJ. Ca2+signalling checkpoints in cancer: remodelling Ca2+for cancer cell proliferation and survival. Nat Rev Cancer. 2008;8:361\u201375.","journal-title":"Nat Rev Cancer"},{"key":"425_CR16","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00424-008-0533-2","volume":"457","author":"M Potier","year":"2008","unstructured":"Potier M, Trebak M. New developments in the signaling mechanisms of the store-operated calcium entry pathway. Pflugers Arch. 2008;457:405\u201315.","journal-title":"Pflugers Arch"},{"key":"425_CR17","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1152\/physiol.00011.2017","volume":"32","author":"M Trebak","year":"2017","unstructured":"Trebak M, Putney JW. ORAI calcium channels. Physiology. 2017;32:332\u201342.","journal-title":"Physiology"},{"key":"425_CR18","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1016\/j.bbamcr.2015.10.003","volume":"1863","author":"I Jardin","year":"2016","unstructured":"Jardin I, Rosado JA. STIM and calcium channel complexes in cancer. Biochim Biophys Acta. 2016;1863:1418\u201326.","journal-title":"Biochim Biophys Acta"},{"key":"425_CR19","doi-asserted-by":"crossref","first-page":"82686","DOI":"10.18632\/oncotarget.12625","volume":"7","author":"W Li","year":"2016","unstructured":"Li W, Dong S, Wei W, Wang G, Zhang A, Pu P, et al. The role of transcriptional coactivator TAZ in gliomas. Oncotarget. 2016;7:82686\u201399.","journal-title":"Oncotarget"},{"key":"425_CR20","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1128\/MCB.01874-07","volume":"28","author":"QY Lei","year":"2008","unstructured":"Lei QY, Zhang H, Zhao B, Zha ZY, Bai F, Pei XH, et al. TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the Hippo pathway. Mol Cell Biol. 2008;28:2426\u201336.","journal-title":"Mol Cell Biol"},{"key":"425_CR21","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1101\/gad.1602907","volume":"21","author":"B Zhao","year":"2007","unstructured":"Zhao B, Wei X, Li W, Udan RS, Yang Q, Kim J, et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev. 2007;21:2747\u201361.","journal-title":"Genes Dev"},{"key":"425_CR22","doi-asserted-by":"publisher","first-page":"19265","DOI":"10.1074\/jbc.M801535200","volume":"283","author":"WI DeHaven","year":"2008","unstructured":"DeHaven WI, Smyth JT, Boyles RR, Bird GS, Putney JW. Complex actions of 2-aminoethyldiphenyl borate on store-operated calcium entry. J Biol Chem. 2008;283:19265\u201373.","journal-title":"J Biol Chem"},{"key":"425_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1469-7793.2001.t01-1-00003.x","volume":"536","author":"M Prakriya","year":"2001","unstructured":"Prakriya M, Lewis RS. Potentiation and inhibition of Ca2+release-activated Ca2+channels by 2-aminoethyldiphenyl borate (2-APB) occurs independently of IP3 receptors. J Physiol. 2001;536:3\u201319.","journal-title":"J Physiol"},{"key":"425_CR24","doi-asserted-by":"publisher","first-page":"21617","DOI":"10.1074\/jbc.M202549200","volume":"277","author":"M Trebak","year":"2002","unstructured":"Trebak M, Bird GSJ, McKay RR, Putney JW. Comparison of human TRPC3 channels in receptor-activated and store-operated modes. Differential sensitivity to channel blockers suggests fundamental differences in channel composition. J Biol Chem. 2002;277:21617\u201323.","journal-title":"J Biol Chem"},{"key":"425_CR25","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1161\/01.RES.0000338496.95579.56","volume":"103","author":"IF Abdullaev","year":"2008","unstructured":"Abdullaev IF, Bisaillon JM, Potier M, Gonzalez JC, Motiani RK, Trebak M. Stim1 and orai1 mediate CRAC currents and store-operated calcium entry important for endothelial cell proliferation. Circ Res. 2008;103:1289\u201399.","journal-title":"Circ Res"},{"key":"425_CR26","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1242\/jcs.023903","volume":"121","author":"JT Smyth","year":"2008","unstructured":"Smyth JT, DeHaven WI, Bird GS, Putney JW. Ca2+-store-dependent and -independent reversal of Stim1 localization and function. J Cell Sci. 2008;121:762\u201372.","journal-title":"J Cell Sci"},{"issue":"Pt 3","key":"425_CR27","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1042\/bj3000665","volume":"300","author":"AJ Morgan","year":"1994","unstructured":"Morgan AJ, Jacob R. Ionomycin enhances Ca2+influx by stimulating store-regulated cation entry and not by a direct action at the plasma membrane. Biochem J. 1994;300(Pt 3):665\u201372.","journal-title":"Biochem J"},{"key":"425_CR28","doi-asserted-by":"crossref","first-page":"12266","DOI":"10.1016\/S0021-9258(18)63852-9","volume":"264","author":"H Takemura","year":"1989","unstructured":"Takemura H, Hughes AR, Thastrup O, Putney JW. Activation of calcium entry by the tumor promoter thapsigargin in parotid acinar cells. Evidence that an intracellular calcium pool, and not an inositol phosphate, regulates calcium fluxes at the plasma membrane. J Biol Chem. 1989;264:12266\u201371.","journal-title":"J Biol Chem"},{"key":"425_CR29","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s00424-013-1254-8","volume":"465","author":"RK Motiani","year":"2013","unstructured":"Motiani RK, Hyzinski-Garcia MC, Zhang X, Henkel MM, Abdullaev IF, Kuo YH, et al. STIM1 and Orai1 mediate CRAC channel activity and are essential for human glioblastoma invasion. Pflugers Arch. 2013;465:1249\u201360.","journal-title":"Pflugers Arch"},{"key":"425_CR30","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00210-007-0243-x","volume":"377","author":"M Asai","year":"2008","unstructured":"Asai M, Takeuchi K, Uchida S, Urushida T, Katoh H, Satoh H, et al. Misinterpretation of the effect of amlodipine on cytosolic calcium concentration with fura-2 fluorospectrometry. Naunyn Schmiedebergs Arch Pharmacol. 2008;377:423\u20137.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"425_CR31","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1038\/sj.onc.1208445","volume":"24","author":"EH Chan","year":"2005","unstructured":"Chan EH, Nousiainen M, Chalamalasetty RB, Schafer A, Nigg EA, Sillje HH. The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1. Oncogene. 2005;24:2076\u201386.","journal-title":"Oncogene"},{"key":"425_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9357","volume":"6","author":"Z Meng","year":"2015","unstructured":"Meng Z, Moroishi T, Mottier-Pavie V, Plouffe SW, Hansen CG, Hong AW, et al. MAP4K family kinases act in parallel to MST1\/2 to activate LATS1\/2 in the Hippo pathway. Nat Commun. 2015;6:8357.","journal-title":"Nat Commun"},{"key":"425_CR33","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.devcel.2015.08.014","volume":"34","author":"Y Zheng","year":"2015","unstructured":"Zheng Y, Wang W, Liu B, Deng H, Uster E, Pan D. Identification of Happyhour\/MAP4K as alternative Hpo\/Mst-like kinases in the Hippo kinase cascade. Dev Cell. 2015;34:642\u201355.","journal-title":"Dev Cell"},{"key":"425_CR34","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/cr.2015.88","volume":"25","author":"R Gong","year":"2015","unstructured":"Gong R, Hong AW, Plouffe SW, Zhao B, Liu G, Yu FX, et al. Opposing roles of conventional and novel PKC isoforms in Hippo-YAP pathway regulation. Cell Res. 2015;25:985\u20138.","journal-title":"Cell Res"},{"key":"425_CR35","doi-asserted-by":"crossref","first-page":"9194","DOI":"10.1016\/S0021-9258(18)98335-3","volume":"268","author":"G Martiny-Baron","year":"1993","unstructured":"Martiny-Baron G, Kazanietz MG, Mischak H, Blumberg PM, Kochs G, Hug H, et al. Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J Biol Chem. 1993;268:9194\u20137.","journal-title":"J Biol Chem"},{"key":"425_CR36","doi-asserted-by":"publisher","first-page":"34709","DOI":"10.1074\/jbc.M302016200","volume":"278","author":"JW Soh","year":"2003","unstructured":"Soh JW, Weinstein IB. Roles of specific isoforms of protein kinase C in the transcriptional control of cyclin D1 and related genes. J Biol Chem. 2003;278:34709\u201316.","journal-title":"J Biol Chem"},{"key":"425_CR37","doi-asserted-by":"publisher","first-page":"15823","DOI":"10.1074\/jbc.271.26.15823","volume":"271","author":"GC Blobe","year":"1996","unstructured":"Blobe GC, Stribling DS, Fabbro D, Stabel S, Hannun YA. Protein kinase C beta II specifically binds to and is activated by F-actin. J Biol Chem. 1996;271:15823\u201330.","journal-title":"J Biol Chem"},{"key":"425_CR38","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1101\/gad.173435.111","volume":"26","author":"B Zhao","year":"2012","unstructured":"Zhao B, Li L, Wang L, Wang CY, Yu J, Guan KL. Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis. Genes Dev. 2012;26:54\u201368.","journal-title":"Genes Dev"},{"key":"425_CR39","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nrm3416","volume":"13","author":"G Halder","year":"2012","unstructured":"Halder G, Dupont S, Piccolo S. Transduction of mechanical and cytoskeletal cues by YAP and TAZ. Nat Rev Mol Cell Biol. 2012;13:591\u2013600.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"425_CR40","doi-asserted-by":"publisher","first-page":"E2595","DOI":"10.1073\/pnas.1504837112","volume":"112","author":"X Shao","year":"2015","unstructured":"Shao X, Li Q, Mogilner A, Bershadsky AD, Shivashankar GV. Mechanical stimulation induces formin-dependent assembly of a perinuclear actin rim. Proc Natl Acad Sci USA. 2015;112:E2595\u20132601.","journal-title":"Proc Natl Acad Sci USA"},{"key":"425_CR41","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.19850","volume":"5","author":"P Wales","year":"2016","unstructured":"Wales P, Schuberth CE, Aufschnaiter R, Fels J, Garcia-Aguilar I, Janning A, et al. Calcium-mediated actin reset (CaAR) mediates acute cell adaptations. Elife. 2016;5:e19850","journal-title":"Elife"},{"key":"425_CR42","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/nmeth.1220","volume":"5","author":"J Riedl","year":"2008","unstructured":"Riedl J, Crevenna AH, Kessenbrock K, Yu JH, Neukirchen D, Bista M, et al. Lifeact: a versatile marker to visualize F-actin. Nat Methods. 2008;5:605\u20137.","journal-title":"Nat Methods"},{"key":"425_CR43","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.yexmp.2011.09.005","volume":"91","author":"H Liu","year":"2011","unstructured":"Liu H, Hughes JD, Rollins S, Chen B, Perkins E. Calcium entry via ORAI1 regulates glioblastoma cell proliferation and apoptosis. Exp Mol Pathol. 2011;91:753\u201360.","journal-title":"Exp Mol Pathol"},{"key":"425_CR44","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1365-2125.1986.tb02874.x","volume":"22","author":"JK Faulkner","year":"1986","unstructured":"Faulkner JK, McGibney D, Chasseaud LF, Perry JL, Taylor IW. The pharmacokinetics of amlodipine in healthy volunteers after single intravenous and oral doses and after 14 repeated oral doses given once daily. Br J Clin Pharmacol. 1986;22:21\u201325.","journal-title":"Br J Clin Pharmacol"},{"key":"425_CR45","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1152\/physrev.00034.2007","volume":"88","author":"SF Steinberg","year":"2008","unstructured":"Steinberg SF. Structural basis of protein kinase C isoform function. Physiol Rev. 2008;88:1341\u201378.","journal-title":"Physiol Rev"},{"key":"425_CR46","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.tcb.2016.05.003","volume":"26","author":"S Sun","year":"2016","unstructured":"Sun S, Irvine KD. Cellular organization and cytoskeletal regulation of the Hippo signaling network. Trends Cell Biol. 2016;26:694\u2013704.","journal-title":"Trends Cell Biol"},{"key":"425_CR47","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1091\/mbc.e13-11-0701","volume":"25","author":"S Mana-Capelli","year":"2014","unstructured":"Mana-Capelli S, Paramasivam M, Dutta S, McCollum D. Angiomotins link F-actin architecture to Hippo pathway signaling. Mol Biol Cell. 2014;25:1676\u201385.","journal-title":"Mol Biol Cell"},{"key":"425_CR48","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ccr.2014.05.001","volume":"26","author":"W Li","year":"2014","unstructured":"Li W, Cooper J, Zhou L, Yang C, Erdjument-Bromage H, Zagzag D, et al. Merlin\/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the Hippo pathway kinases Lats1 and 2 in the nucleus. Cancer Cell. 2014;26:48\u201360.","journal-title":"Cancer Cell"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41388-018-0425-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41388-018-0425-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41388-018-0425-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:12:58Z","timestamp":1684617178000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-018-0425-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,6]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["425"],"URL":"https:\/\/doi.org\/10.1038\/s41388-018-0425-7","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,6]]},"assertion":[{"value":"15 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}